However, further well‐organized and intensive prospective clinical studies are required to analyze the correlation between total dietary selenium intake, GPX4 activity, chemotherapy response, and survival outcomes, as well as other information such as medication history like statins, whose usage may cause impaired selenoprotein expression in patients with lung cancer with BM.67 Here, SELENOS is linked to lung carcinoma.